相关实验视频

Updated: Sep 19, 2025

Culturing and Genetically Manipulating Entomopathogenic Nematodes

Culturing and Genetically Manipulating Entomopathogenic Nematodes

Published on: March 31, 2022

昆虫病原性线虫:商业用途和未来的前景

Tshimangadzo Ramakuwela¹, Eustachio Tarasco², Norberto Chavarría-Hernández³

¹Department of Plant and Soil Sciences, University of Pretoria, Hatfield, Pretoria, South Africa.

Journal of invertebrate pathology

|June 18, 2025

概括

昆虫病原性线虫 (EPN) 在过去的100年里取得了重大进展,为昆虫害虫提供了安全,可持续的生物控制. 未来的创新有望在农业中得到更广泛的采用.

科学领域:

农业科学农业科学
昆虫学昆虫学是一门学科.
生物控制生物控制

背景情况:

昆虫病原性线虫 (EPN) 已经研究,开发和商业化了100年.
现在,EPN产品在全球范围内可用,基于有限数量的物种.
本文审查了EPN在农业中的商业化和使用情况,强调了它们在综合性害虫防治中的作用.

研究的目的:

审查EPN在农业中的商业化和应用.
为了证明EPN对化学农药的优势.
探索EPN商业化和采用的未来潜力.

主要方法:

关于EPN研究,开发和商业化的文献综述.
分析EPN在田间作物 (如玉米) 和农业林业中的应用.
探索EPN技术和市场扩张的未来进展.

主要成果:

与化学农药相比,EPN具有显著的优势,包括安全性和环境效益.
EPN是生物控制昆虫害虫的有效工具.
目前的EPN产品是基于有限数量的物种,但广泛可用.

结论:

对于可持续的综合性害虫防治策略来说,EPN至关重要.
未来在基因改进,应用技术和生产方面的进步是扩大EPN使用的关键.
在全球范围内,EPN有潜力成为害虫管理的基石.

关键词:

农业林业生态系统的生态系统有益的线虫是有益的线虫.生物控制产品生物控制产品商业化商业化玉米的农业生态系统

更多相关视频

Mass Production of Entomopathogenic Fungi, Metarhizium robertsii and Metarhizium pinghaense, for Commercial Application Against Insect Pests

Mass Production of Entomopathogenic Fungi, Metarhizium robertsii and Metarhizium pinghaense, for Commercial Application Against Insect Pests

Published on: March 31, 2022

Development of Metarhizium anisopliae as a Mycoinsecticide: From Isolation to Field Performance

Development of Metarhizium anisopliae as a Mycoinsecticide: From Isolation to Field Performance

Published on: July 30, 2017

相关概念视频

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.